[
    {
      "sourceUrl": "http://pharma-dept.gov.in/studyreports/study-report-bridging-academia-industry-gap-achieve-self-reliance",
      "documents": [
        {
          "year": 2024,
          "name": "Final Study Report - Bridging Academia-Industry Gap to achieve Self-reliance",
          "type": "Study Report",
          "description": "This report analyzes the pharmaceutical sector gap between academia and industry to enhance self-reliance.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Study%20Report%20-%20Bridging%20Academia-Industry%20Gap%20to%20achieve%20Self-reliance_0.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/studyreports/study-report-analysis-leveraging-patent-cliff-drug-sales-worth-usd-251-billion-going",
      "documents": [
        {
          "year": 2024,
          "name": "FINAL-An analysis on leveraging the patent cliff",
          "type": "Study Report",
          "description": "A report analyzing how to leverage the patent cliff and examining various drug pricing methodologies for drugs going off-patent.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/FINAL-An%20analysis%20on%20leveraging%20the%20patent%20cliff.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/studyreports/report-strategy-leveraging-asean-fta-and-trade-potential-middle-east-countries-pharma",
      "documents": [
        {
          "year": 2023,
          "name": "Updated Strategy for Leveraging ASEAN FTA and trade potential with the Middle East Countries for Pharma Sector in India Final - ISID",
          "type": "Industry Strategy Document",
          "description": "This report outlines strategies for leveraging the ASEAN FTA and trade opportunities with Middle Eastern countries for India's pharmaceutical sector.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Updated%20Strategy%20for%20Leveraging%20ASEAN%20FTA%20and%20trade%20potential%20with%20the%20Middle%20East%20Countries%20for%20Pharma%20Sector%20in%20India%20Final%20-%20ISID.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/study-report",
      "documents": [
        {
          "year": 2024,
          "name": "Study report on Bridging Academia-Industry Gap to achieve Self-reliance",
          "type": "Sectoral Publication",
          "description": "Analyzes approaches to bridge the gap between academia and industry for achieving self-reliance in the pharmaceutical sector.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Study%20Report%20-%20Bridging%20Academia-Industry%20Gap%20to%20achieve%20Self-reliance_0.pdf"
        },
        {
          "year": 2024,
          "name": "Study Report on Impact of the Drug Price Control Order (DPCO) 2013 on the price of Cardiac stents Knee implants and six medical devices on industry and consumers in terms of availability and affordability",
          "type": "Sectoral Publication",
          "description": "Examines the impact of DPCO 2013 on pricing, availability, and affordability of medical devices for industry and consumers.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/FINAL-Impact%20of%20the%20DPCO%202013%20on%20the%20price%20of%20Cardiac%20stents%20Knee%20implants%20.pdf"
        },
        {
          "year": 2024,
          "name": "Study report on An analysis on leveraging the patent cliff, with drug sales worth USD 251 billion going off-patent and to analyses the different drug pricing methodologies particularly w.r.t. these patented drugs going off-patent",
          "type": "Sectoral Publication",
          "description": "Analyzes the patent cliff in pharmaceuticals and various pricing methodologies for drugs going off-patent.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/FINAL-An%20analysis%20on%20leveraging%20the%20patent%20cliff.pdf"
        },
        {
          "year": 2024,
          "name": "Study on Upgrading NIPERs to meet evolving needs of Pharmaceutical business and NIPERs in top 50 in world ranking",
          "type": "Sectoral Publication",
          "description": "Explores strategies to upgrade NIPERs to meet global pharmaceutical business standards and aim for top world rankings.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final-Upgrading%20NIPERs%20to%20meet%20evolving%20needs%20of%20Pharmaceutical%20business%20and%20NIPERs%20in%20top%2050%20in%20world%20ranking.pdf"
        },
        {
          "year": 2023,
          "name": "Study on CRO Sector in India",
          "type": "Sectoral Publication",
          "description": "Provides an overview and analysis of the Contract Research Organization (CRO) sector in India.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/CRO%20Market%20Report_High%20Resolution.pdf"
        },
        {
          "year": 2023,
          "name": "Report on Strategy for Leveraging ASEAN FTA and Trade Potential with the Middle East Countries for Pharma Sector in India",
          "type": "Industry Strategy Document",
          "description": "Outlines strategies for maximizing benefits from ASEAN FTA and trade with Middle East in the pharma sector.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Updated%20Strategy%20for%20Leveraging%20ASEAN%20FTA%20and%20trade%20potential%20with%20the%20Middle%20East%20Countries%20for%20Pharma%20Sector%20in%20India%20Final%20-%20ISID.pdf"
        },
        {
          "year": 2023,
          "name": "Report on Survey of Pharma Clusters",
          "type": "Sectoral Publication",
          "description": "Presents findings from a survey of pharmaceutical manufacturing clusters across India.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Report-Survey%20of%20Pharma%20Clusters.pdf"
        },
        {
          "year": 2023,
          "name": "Report on Survey of Medical Devices Clusters",
          "type": "Sectoral Publication",
          "description": "Details survey results and insights into India's medical devices manufacturing clusters.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Report-Survey%20of%20Medical%20Devices%20Clusters.pdf"
        },
        {
          "year": 2023,
          "name": "Report on Survey for Novel/ Innovative and Cost-effective Technologies for Productoion of APIs",
          "type": "Sectoral Publication",
          "description": "Surveys innovative and cost-effective technologies for the production of Active Pharmaceutical Ingredients (APIs).",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Report-Survey%20of%20Novel%20Technologies%20for%20Productoion%20of%20APIs.pdf"
        },
        {
          "year": 2023,
          "name": "Report on Final Boosting of Medical Devices Industry",
          "type": "Industry Strategy Document",
          "description": "Discusses strategies and recommendations to boost India's medical devices industry.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20Boosting%20of%20Medical%20Devices%20Industry%20-%20Report%20-%202023.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/annual-report",
      "documents": [
        {
          "year": 2024,
          "name": "Annual Report 2024-25",
          "type": "Annual Report",
          "description": "Comprehensive review of departmental activities, policies, and achievements for the year 2024-25.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Final%20English%202024-25%20AR%20%281%29.pdf"
        },
        {
          "year": 2023,
          "name": "Annual Report 2023-24",
          "type": "Annual Report",
          "description": "Detailed account of the Department of Pharmaceuticals' operations and key developments in 2023-24.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/English%20version%20of%20Annual%20Report%202023-24.pdf"
        },
        {
          "year": 2022,
          "name": "Annual Report 2022-23",
          "type": "Annual Report",
          "description": "Report covering the department's initiatives, outcomes, and sector overview for 2022-23.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Annual%20Report%202022-23%20Final-3.pdf"
        },
        {
          "year": 2021,
          "name": "Annual Report 2021-22",
          "type": "Annual Report",
          "description": "Annual summary of policy measures and pharmaceutical sector development for 2021-22.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/English%20Annual%20Report%202021-22%20%281%29.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/important-document",
      "documents": [
        {
          "year": 2024,
          "name": "Modification in the guidelines of Production Linked Incentive (PLI) Scheme Bulk Drugs",
          "type": "Industry Strategy Document",
          "description": "Notifies modifications in the guidelines of the PLI scheme for Bulk Drugs.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Corrigendum%20Under%20PLI%20scheme%20for%20Bulk%20Drugs%2025.09.2024.pdf"
        },
        {
          "year": 2024,
          "name": "Notification of the modification in the clauses under subscheme Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS)",
          "type": "Industry Strategy Document",
          "description": "Announces modifications under the RPTUAS subscheme for technology upgradation.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Corrigendum%20RPTUAS.pdf"
        },
        {
          "year": 2024,
          "name": "Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 - reg",
          "type": "Whitepaper",
          "description": "Details the Uniform Code for Pharmaceutical Marketing Practices 2024 for industry compliance.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/UCPMP%202024%20for%20website_0.pdf"
        },
        {
          "year": 2024,
          "name": "Revised Guidelines for the Scheme - Strengthening of Pharmaceuticals Industry (SPI), Dated 14th March 2024",
          "type": "Sectoral Publication",
          "description": "Revised guidelines for the Strengthening of Pharmaceuticals Industry scheme.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Revised%20guidelines%20SPI%20dated%2014.03.2024.pdf"
        },
        {
          "year": 2024,
          "name": "Guidelines for the Scheme (Strengthening of Pharmaceuticals Industry (SPI)) - Revamping of the PTUAS sub-scheme and Notification of the modification in the guidelines - reg.",
          "type": "Sectoral Publication",
          "description": "Provides guidelines and notifications for revamping SPI and PTUAS.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Guidelines%20PTUAS.pdf"
        },
        {
          "year": 2024,
          "name": "Modifications/ Clarifications in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals - Dated 11th March, 2024",
          "type": "Industry Strategy Document",
          "description": "Offers clarifications in the operational guidelines for the PLI Scheme for Pharmaceuticals.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Corrigendum%20.pdf"
        },
        {
          "year": 2024,
          "name": "Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country (PLI BD)- reg",
          "type": "Industry Strategy Document",
          "description": "Announces changes in PLI guidelines for APIs and related pharmaceutical ingredients.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Corrigendum%20dated%2012.03.2024_0.pdf"
        },
        {
          "year": 2024,
          "name": "Modifications in the guidelines of Production Linked Incentive scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) relating to revision of Scheduled Commercial Operation Date (SCOD) and invocation of bank guarantee - reg",
          "type": "Industry Strategy Document",
          "description": "Details modifications in the PLI scheme for medical devices regarding SCOD and bank guarantees.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Corrigendum%20MD.pdf"
        },
        {
          "year": 2023,
          "name": "Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of Medical Devices (PLI - MD) to invite applications for the eligible products as per Annexure-1A for Category-B applicant dated 19.12.2023",
          "type": "Industry Strategy Document",
          "description": "Guidelines modification for PLI scheme applications—medical devices (Category B, Dec 2023).",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Amendment%20in%20the%20Guidelines%20Annexure-1%20and%201A%20dated%2019.12.2023-1-5.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/policy",
      "documents": [
        {
          "year": 2024,
          "name": "Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024",
          "type": "Industry Code",
          "description": "Sets standards for ethical marketing practices in the pharmaceutical industry.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/UCPMP%202024%20for%20website.pdf"
        },
        {
          "year": 2024,
          "name": "Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024",
          "type": "Industry Code",
          "description": "Defines the marketing code and best practices for the medical devices sector.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/UCMPMD_0.pdf"
        },
        {
          "year": 2023,
          "name": "National Medical Device Policy 2023",
          "type": "Sectoral Policy",
          "description": "Gazette notification detailing the framework and objectives of the medical devices policy.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Gazette%20Notification%20%20National%20Medical%20Devices%20Policy%202023.pdf"
        },
        {
          "year": 2023,
          "name": "Strategy Document on National Medical Devices Policy, 2023",
          "type": "Industry Strategy Document",
          "description": "Comprehensive strategic roadmap for the implementation of the National Medical Devices Policy.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Strategy%20Document%20on%20NMDP%202023_0.pdf"
        }
      ]
    },
    {
      "sourceUrl": "http://pharma-dept.gov.in/studyreports/report-assessment-skill-requirement-indian-pharma-industry",
      "documents": [
        {
          "year": 2023,
          "name": "Assessment of skill requirement of Indian Pharma Industry Under PMPDS scheme",
          "type": "Sectoral Publication",
          "description": "Report assessing the skill requirement of the Indian pharmaceutical industry under the PMPDS scheme.",
          "documentUrl": "https://pharma-dept.gov.in/sites/default/files/Assessment%20of%20skill%20requirement%20of%20Indian%20Pharma%20Industry_Under%20PMPDS%20scheme%20%281%29.pdf"
        }
      ]
    }
  ]